Tag: Cereblon E3 ligase modulator

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Cereblon E3 ligase modulator

J&J secures EMA backing for earlier CAR-T use in multiple myeloma - BioPharma Dive

Added to Collection on: 2024-02-23 17:07:20

Tags for this article:

Orphan drugs
CAR T-cell therapy
Antineoplastic drugs
Immunosuppressants
Idecabtagene vicleucel
Multiple myeloma
CAR T cell
Lenalidomide
Ciltacabtagene autoleucel
Cereblon E3 ligase modulator
Bristol-Myers Squibb
B-cell maturation antigen

Click the tags to see associated articles and topics

View Article Details
Isa-EloPD Shows Promise in Multiple Myeloma Management - Targeted Oncology

Added to Collection on: 2024-02-28 18:07:51

Tags for this article:

Orphan drugs
Elotuzumab
Isatuximab
Multiple myeloma
Cereblon E3 ligase modulator
Lenalidomide
Pomalidomide
CD38
Selinexor
Daratumumab
Dexamethasone

Click the tags to see associated articles and topics

View Article Details
Biotech Stock Roundup: MRNA Up on Vaccine Data, BMY's Updates & More News

Added to Collection on: 2024-04-10 17:32:13

Tags for this article:

Orphan drugs
Antineoplastic drugs
Teratogens
Cancer immunotherapy
Pembrolizumab
Multiple myeloma
MRNA-4157/V940
Cereblon E3 ligase modulator
Cetuximab
Takeda Oncology
Carfilzomib
United States

Click the tags to see associated articles and topics

View Article Details
Induction and Transplant Outcomes Improve With Quadruplet NDMM Regimen

Added to Collection on: 2024-05-24 21:18:47

Tags for this article:

Orphan drugs
Immunosuppressants
Antineoplastic drugs
Multiple myeloma
Aromatic amines
Daratumumab
Pyrazines
Lenalidomide
Dexamethasone
Bortezomib
Minimal residual disease
Cereblon E3 ligase modulator

Click the tags to see associated articles and topics

View Article Details
Daratumumab Treatment Advancements in Newly Diagnosed Multiple Myeloma

Added to Collection on: 2024-06-03 16:07:51

Tags for this article:

Orphan drugs
Immunosuppressants
Antineoplastic drugs
Pyrazines
Teratogens
Multiple myeloma
CD38
Carfilzomib
Lenalidomide
Bortezomib
Cereblon E3 ligase modulator
Minimal residual disease
Dexamethasone

Click the tags to see associated articles and topics

View Article Details
Belantamab Mafodotin–Based PFS Benefits in Difficult-to-Treat R/R Myeloma Subgroups

Added to Collection on: 2024-07-01 13:06:37

Tags for this article:

Orphan drugs
Multiple myeloma
Belantamab mafodotin
Daratumumab
Bortezomib
Antibody-drug conjugate
Lenalidomide
Monomethyl auristatin F
Proteasome inhibitor
Dexamethasone
Cereblon E3 ligase modulator
B-cell maturation antigen

Click the tags to see associated articles and topics

View Article Details
Carvykti Demonstrates Clinically Meaningful Improvement in Patients with Relapsed or ...

Added to Collection on: 2024-07-03 15:46:15

Tags for this article:

Orphan drugs
Multiple myeloma
Daratumumab
Elotuzumab
Carfilzomib
Lenalidomide
Ciltacabtagene autoleucel
Pomalidomide
Cereblon E3 ligase modulator
Bortezomib
CAR T cell
B-cell maturation antigen

Click the tags to see associated articles and topics

View Article Details